Literature DB >> 15385467

Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness).

Illona Gillette-Ferguson1, Amy G Hise, Helen F McGarry, Joseph Turner, Andrew Esposito, Yan Sun, Eugenia Diaconu, Mark J Taylor, Eric Pearlman.   

Abstract

Endosymbiotic Wolbachia bacteria are abundant in the filarial nematodes that cause onchocerciasis (river blindness), including the larvae (microfilariae) that migrate into the cornea. Using a mouse model of ocular onchocerciasis, we recently demonstrated that it is these endosymbiotic bacteria rather than the nematodes per se that induce neutrophil infiltration to the corneal stroma and loss of corneal clarity (Saint Andre et al., Science 295:1892-1895, 2002). To better understand the role of Wolbachia organisms in the pathogenesis of this disease, we examined the fate of these bacteria in the cornea by immunoelectron microscopy. Microfilariae harboring Wolbachia organisms were injected into mouse corneas, and bacteria were detected with antibody to Wolbachia surface protein. Within 18 h of injection, neutrophils completely surrounded the nematodes and were in close proximity to Wolbachia organisms. Wolbachia surface protein labeling was also prominent in neutrophil phagosomes, indicating neutrophil ingestion of Wolbachia organisms. Furthermore, the presence of numerous electron-dense granules around the phagosomes indicated that neutrophils were activated. To determine if Wolbachia organisms directly activate neutrophils, peritoneal neutrophils were incubated with either parasite extracts containing Wolbachia organisms, parasite extracts depleted of Wolbachia organisms (by antibiotic treatment of worms), or Wolbachia organisms isolated from filarial nematodes. After 18 h of incubation, we found that isolated Wolbachia organisms stimulated production of tumor necrosis factor alpha and CXC chemokines macrophage inflammatory protein 2 and KC by neutrophils in a dose-dependent manner. Similarly, these cytokines were induced by filarial extracts containing Wolbachia organisms but not by Wolbachia-depleted extracts. Taken together, these findings indicate that neutrophil activation is an important mechanism by which Wolbachia organisms contribute to the pathogenesis of ocular onchocerciasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385467      PMCID: PMC517527          DOI: 10.1128/IAI.72.10.5687-5692.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin.

Authors:  A Hoerauf; L Volkmann; K Nissen-Paehle; C Schmetz; I Autenrieth; D W Büttner; B Fleischer
Journal:  Trop Med Int Health       Date:  2000-04       Impact factor: 2.622

Review 2.  Neutrophil production of IL-12 and other cytokines during microbial infection.

Authors:  Eric Y Denkers; Laura Del Rio; Soumaya Bennouna
Journal:  Chem Immunol Allergy       Date:  2003

3.  The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness.

Authors:  Amélie v Saint André; Nathan M Blackwell; Laurie R Hall; Achim Hoerauf; Norbert W Brattig; Lars Volkmann; Mark J Taylor; Louise Ford; Amy G Hise; Jonathan H Lass; Eugenia Diaconu; Eric Pearlman
Journal:  Science       Date:  2002-03-08       Impact factor: 47.728

4.  Some observations on the ocular pathology of onchocerciasis.

Authors:  E V Paul; L E Zimmerman
Journal:  Hum Pathol       Date:  1970-12       Impact factor: 3.466

5.  Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis.

Authors:  S J Ackerman; G J Gleich; P F Weller; E A Ottesen
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi.

Authors:  S Townson; D Hutton; J Siemienska; L Hollick; T Scanlon; S K Tagboto; M J Taylor
Journal:  Ann Trop Med Parasitol       Date:  2000-12

Review 7.  Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness).

Authors:  E Pearlman; L R Hall
Journal:  Parasite Immunol       Date:  2000-12       Impact factor: 2.280

8.  Production of key molecules by ocular neutrophils early after herpetic infection of the cornea.

Authors:  M Daheshia; S Kanangat; B T Rouse
Journal:  Exp Eye Res       Date:  1998-12       Impact factor: 3.467

9.  The role of eosinophils and neutrophils in helminth-induced keratitis.

Authors:  E Pearlman; L R Hall; A W Higgins; D S Bardenstein; E Diaconu; F E Hazlett; J Albright; J W Kazura; J H Lass
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-06       Impact factor: 4.799

10.  Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins.

Authors:  G Wildenburg; K Darge; J Knab; F W Tischendorf; I Bonow; D W Büttner
Journal:  Trop Med Parasitol       Date:  1994-06
View more
  20 in total

1.  CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis.

Authors:  Michelle Lin; Eric Carlson; Eugenia Diaconu; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2006-11-16       Impact factor: 4.962

2.  Wolbachia in filarial parasites: targets for filarial infection and disease control.

Authors:  Kelly L Johnston; Mark J Taylor
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

3.  Wolbachia- and Onchocerca volvulus-induced keratitis (river blindness) is dependent on myeloid differentiation factor 88.

Authors:  Illona Gillette-Ferguson; Amy G Hise; Yan Sun; Eugenia Diaconu; Helen F McGarry; Mark J Taylor; Eric Pearlman
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 4.  Gene Transfer Agents in Symbiotic Microbes.

Authors:  Steen Christensen; Laura R Serbus
Journal:  Results Probl Cell Differ       Date:  2020

Review 5.  Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.

Authors:  Francesca Tamarozzi; Alice Halliday; Katrin Gentil; Achim Hoerauf; Eric Pearlman; Mark J Taylor
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells.

Authors:  Tyler D Scherr; Christelle M Roux; Mark L Hanke; Amanda Angle; Paul M Dunman; Tammy Kielian
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Toll-like receptor 2 regulates CXC chemokine production and neutrophil recruitment to the cornea in Onchocerca volvulus/Wolbachia-induced keratitis.

Authors:  Illona Gillette-Ferguson; Katrin Daehnel; Amy G Hise; Yan Sun; Eric Carlson; Eugenia Diaconu; Helen F McGarry; Mark J Taylor; Eric Pearlman
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

8.  Wolbachia endosymbiont of Brugia malayi elicits a T helper type 17-mediated pro-inflammatory immune response through Wolbachia surface protein.

Authors:  Manisha Pathak; Meenakshi Verma; Mrigank Srivastava; Shailja Misra-Bhattacharya
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

9.  Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide.

Authors:  Yan Sun; Todd Fox; Gautam Adhikary; Mark Kester; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2008-04-17       Impact factor: 4.962

10.  Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis.

Authors:  Joseph D Turner; R Stuart Langley; Kelly L Johnston; Katrin Gentil; Louise Ford; Bo Wu; Maia Graham; Faye Sharpley; Barton Slatko; Eric Pearlman; Mark J Taylor
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.